Labrys Biologics, Inc. — Form D

Labrys Biologics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-28. The offering totals $31.0M, of which $14.6M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2012-12-28
• Form: D
• Accession: 0001140361-12-053041
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $31.0M
• Amount sold: $14.6M
• Remaining: $16.4M
• Investors: 5
• Date of first sale: 2012-12-21
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-189143

Issuer

• Name: Labrys Biologics, Inc.
• CIK: 0001564179
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 1700 OWENS STREET, SAN FRANCISCO, CA, 94158
• Phone: 415-800-0800

Officers, directors & promoters (9)

More

• CIK 1564179 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search